keyword
https://read.qxmd.com/read/38680712/clinical-characteristics-and-outcomes-in-hospitalized-patients-with-covid-19-and-cancer-history-a-multicenter-cross-sectional-study-in-southwestern-iran
#41
JOURNAL ARTICLE
Javad Zarei, Abbas Sheikhtaheri, Mehrnaz Ahmadi, Maria Cheraghi, Abdolhassan Talaiezadeh, Adeleh Khazami
Background: Cancer patients are more exposed to opportunistic infections, such as COVID-19, due to their poor health status. This study aimed to identify the clinical characteristics of cancer and non-cancer patients with COVID-19 that may lead to death, intubation, and ICU admission. Materials and Methods: A Multicenter Cross-Sectional study was conducted on confirmed COVID-19 adult patients with and without a history of cancer from March 2019 to March 2021. Demographic and clinical features, ICU admission, intubation, and discharge status have been extracted from patients' medical records...
January 1, 2024: International Journal of Hematology-oncology and Stem Cell Research
https://read.qxmd.com/read/38680711/results-of-autologous-hematopoietic-stem-cell-transplantation-in-patients-with-multiple-myeloma-mm-and-renal-impairment-a-retrospective-single-center-study
#42
JOURNAL ARTICLE
Maiia Soloveva, Maxim Solovev, Daria Mironova, Larisa Mendeleeva
Background: To assess the efficacy of autologous hematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM) patients with acute renal failure. Materials and Methods: A retrospective single-center study included 64 patients (30 men, 34 women) with MM and kidney damage at the onset of the disease, aged 19 to 65 years (median 54), who underwent auto-HSCT from 2013 to 2019. 23 patients (36%) were dialysis-dependent at the time of diagnosis. The analysis was carried out in two groups: the "HD-" group (patients who were independent of hemodialysis during auto-HSCT, n = 54), and the "HD +" group (patients who underwent auto-HSCT while treated with programmed hemodialysis, n = 10)...
January 1, 2024: International Journal of Hematology-oncology and Stem Cell Research
https://read.qxmd.com/read/38680707/prevalence-and-risk-factors-of-wound-complications-after-transtibial-amputation-in-patients-with-diabetic-foot
#43
JOURNAL ARTICLE
Young Uk Park, Seong Hyuk Eim, Young Wook Seo
BACKGROUND: Diabetic foot (DMF) complications are common and are increasing in incidence. Risk factors related to wound complications are yet to be established after trans-tibial amputation under the diagnosis of DMF infection. AIM: To analyze the prognosis and risk factors related to wound complications after transtibial amputation in patients with diabetes. METHODS: This retrospective cohort study included seventy-two patients with DMF complications who underwent transtibial amputation between April 2014 and March 2023...
April 15, 2024: World Journal of Diabetes
https://read.qxmd.com/read/38680517/guideline-for-the-management-of-clostridioides-difficile-infection-in-pediatric-patients-with-cancer-and-hematopoietic-cell-transplantation-recipients-2024-update
#44
REVIEW
Priya Patel, Paula D Robinson, Brian T Fisher, Robert Phillips, Jessica E Morgan, Thomas Lehrnbecher, Susan Kuczynski, Christa Koenig, Gabrielle M Haeusler, Adam Esbenshade, Caitlin Elgarten, Nathan Duong, Caroline Diorio, Elio Castagnola, Melissa P Beauchemin, Roland A Ammann, L Lee Dupuis, Lillian Sung
Our objective was to update a clinical practice guideline for the prevention and treatment of Clostridioides difficile infection (CDI) in pediatric patients with cancer and hematopoietic cell transplantation recipients. We reconvened an international multi-disciplinary panel. A systematic review of randomized controlled trials (RCTs) for the prevention or treatment of CDI in any population was updated and identified 31 new RCTs. Strong recommendations were made to use either oral metronidazole or oral vancomycin for non-severe CDI treatment, and to use either oral vancomycin or oral fidaxomicin for severe CDI...
June 2024: EClinicalMedicine
https://read.qxmd.com/read/38679228/donor-screening-for-fecal-microbiota-transplantation-with-a-direct-stool-testing-based-strategy-a-prospective-cohort-study
#45
JOURNAL ARTICLE
Debora Rondinella, Gianluca Quaranta, Tommaso Rozera, Pasquale Dargenio, Giovanni Fancello, Irene Venturini, Alessandra Guarnaccia, Serena Porcari, Stefano Bibbò, Maurizio Sanguinetti, Antonio Gasbarrini, Luca Masucci, Giovanni Cammarota, Gianluca Ianiro
Fecal microbiota transplantation (FMT) is effective against recurrent Clostridioides difficile infection (rCDI), but its safety is jeopardized by the potential transmission of pathogens, so international guidelines recommend either a quarantine or a direct stool testing. Whereas reports of the quarantine-based approach are emerging, data on the direct testing-based approach are not available. Our aim is to report outcomes of a donor screening framework for FMT including direct stool testing. In this prospective cohort study, all donor candidates recruited at our FMT centre underwent a four-step screening process to be enrolled as actual donors...
April 26, 2024: Microbes and Infection
https://read.qxmd.com/read/38679014/the-predictors-and-risk-factors-of-two-year-rejection-in-renal-transplant-patients-a-multicenter-case-control-study
#46
JOURNAL ARTICLE
Maram M Alsulami, Nouf E Al-Otaibi, Walaa A Alshahrani, Abdulrahman Altheaby, Khalefa M Al Thiab, Lina I Alnajjar, Mohamed A Albekery, Reem F Almutairy, Mohammed Y Asiri, Sumaya N AlMohareb, Faisal Aqeel Alsehli, Alanoud T Binthuwaini, Alaa Almagthali, Sarah S Alwaily, Arwa Y Alzahrani, Fisal Alrohile, Afnan E Alqurashi, Hanan Alshareef, Hassan Almarhabi, Aisha Alharbi, Hessah Alrashidi, Raghad M Alamri, Faisal N Alnahari, Bilal Mohsin, Nasser O Odah, Wael T Habhab, Yasir A Alfi, Haifa A Alhaidal, Munirah Alghwainm, Khalid Al Sulaiman
INTRODUCTION: Kidney transplantation is a definitive treatment for end-stage renal disease. It is associated with improved life expectancy and quality of life. One of the most common complications following kidney transplantation is graft rejection. To our knowledge, no previous study has identified rejection risk factors in kidney transplant recipients in Saudi Arabia. Therefore, the purpose of this study was to determine the specific risk factors of graft rejection. METHODS: A multicenter case-control study was conducted at four transplant centers in Saudi Arabia...
April 26, 2024: American Journal of Nephrology
https://read.qxmd.com/read/38678586/recipient-donor-sex-combinations-in-solid-organ-transplantation-and-impact-on-clinical-outcome-a-scoping-review
#47
REVIEW
Christian Tibor Josef Magyar, Charlene Pierrine Gretener, Patricia Baldi, Federico Storni, Corina Kim-Fuchs, Daniel Candinas, Annalisa Berzigotti, Matthias Knecht, Guido Beldi, Cédric Hirzel, Daniel Sidler, David Reineke, Vanessa Banz
INTRODUCTION: Solid organ transplantation (SOT) is a lifesaving treatment for end-stage organ failure. Although many factors affect the success of organ transplantation, recipient and donor sex are important biological factors influencing transplant outcome. However, the impact of the four possible recipient and donor sex combinations (RDSC) on transplant outcome remains largely unclear. METHODS: A scoping review was carried out focusing on studies examining the association between RDSC and outcomes (mortality, graft rejection, and infection) after heart, lung, liver, and kidney transplantation...
May 2024: Clinical Transplantation
https://read.qxmd.com/read/38678508/current-status-and-new-experimental-diagnostic-methods-of-invasive-fungal-infections-after-hematopoietic-stem-cell-transplantation
#48
REVIEW
Zhenhua Tang, HaiTao Wang, Yuankai Liu, Chen Wang, Xinye Li, Qiong Yang
Invasive fungal infections (IFIs) are common and life-threatening complications in post-hematopoietic stem cell transplantation (post-HSCT) recipients, Severe IFIs can lead to systemic infection and organ damage, which results in high mortality in HSCT recipients. With the development of the field of fungal infection diagnosis, more and more advanced non-culture diagnostic tools have been developed, such as glip biosensors, metagenomic next-generation sequencing, Magnetic Nanoparticles and Identified Using SERS via AgNPs+  , and artificial intelligence-assisted diagnosis...
April 28, 2024: Archives of Microbiology
https://read.qxmd.com/read/38678093/the-addition-of-bortezomib-to-rituximab-high-dose-cytarabine-and-dexamethasone-in-relapsed-or-refractory-mantle-cell-lymphoma-a-randomized-open-label-phase-iii-trial-of-the-european-mantle-cell-lymphoma-network
#49
JOURNAL ARTICLE
Luca Fischer, Linmiao Jiang, Jan Dürig, Christian Schmidt, Stephan Stilgenbauer, Krimo Bouabdallah, Philippe Solal-Celigny, Christian W Scholz, Pierre Feugier, Maike de Wit, Ralf Ulrich Trappe, Michael Hallek, Ullrich Graeven, Mathias Hänel, Martin Hoffmann, Vincent Delwail, Margaret Macro, Jochen Greiner, Aristoteles A N Giagounidis, Beate Dargel, Eric Durot, Charles Foussard, Elisabeth Silkenstedt, Oliver Weigert, Christiane Pott, Wolfram Klapper, Wolfgang Hiddemann, Michael Unterhalt, Eva Hoster, Vincent Ribrag, Martin Dreyling
The therapy of relapsed or refractory (r/r) mantle cell lymphoma (MCL) patients remains a major clinical challenge to date. We conducted a randomized, open-label, parallel-group phase-III trial hypothesizing superior efficacy of rituximab, high-dose cytarabine and dexamethasone with bortezomib (R-HAD + B) versus without (R-HAD) in r/r MCL ineligible for or relapsed after autologous stem cell transplant (ASCT). Primary endpoint was time to treatment failure (TTF), secondary endpoints included response rates, progression free survival, overall survival, and safety...
April 27, 2024: Leukemia
https://read.qxmd.com/read/38677352/lung-donor-bronchoalveolar-lavage-positivity-incidence-risk-factors-and-lung-transplant-recipients-outcome
#50
JOURNAL ARTICLE
Jacopo Fumagalli, Veronica Punzi, Vittorio Scaravilli, Serena Maria Passamonti, Letizia Corinna Morlacchi, Valeria Rossetti, Anna Maraschini, Caterina Matinato, Margherita Brivio, Ilaria Righi, Francesco Blasi, Alessandra Bandera, Lorenzo Rosso, Mauro Panigada, Alberto Zanella, Giacomo Grasselli
BACKGROUND: Inconsistent data exists regarding the risk factors for bronchoalveolar lavage (BAL) positivity in lung donors, the incidence of donor-derived infections (DDI), and the effect of BAL positivity on lung transplant (LuTx) recipients' outcome. METHODS: A retrospective analysis was conducted on consecutive LuTx at a single center from January 2016 to December 2022. Donors' data, including characteristics, graft function and BAL samples were collected pre-procurement...
April 25, 2024: Journal of Heart and Lung Transplantation
https://read.qxmd.com/read/38676303/clinical-analysis-of-air-leak-syndrome-following-allogeneic-hematopoietic-stem-cell-transplantation-in-pediatric-patients
#51
JOURNAL ARTICLE
Wei Zhao, Rong Wang, Man Chen
BACKGROUND: Air-leak syndrome (ALS) is considered as an independent risk factor for poor prognosis in adult patients who had received hematopoietic stem cell transplantation (HSCT), and the 5-year overall survival (OS) of ALS is less than 30%. However, the clinical features of ALS among post-transplant pediatric patients have rarely been explored. PROCEDURES: We retrospectively reviewed 2206 pediatric patients who had received an allo-HSCT between January 2013 and December 2019 at the Hebei Yanda Lu Daopei Hospital, and analyzed the role of ALS in prognosis following HSCT...
April 26, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38675960/mesenchymal-stem-cell-derived-exosomes-attenuate-murine-cytomegalovirus-infected-pneumonia-via-nf-%C3%AE%C2%BAb-nlrp3-signaling-pathway
#52
JOURNAL ARTICLE
Fei Chen, Zhida Chen, Hui-Ting Wu, Xin-Xiang Chen, Peiqi Zhan, Zheng-Yi Wei, Zizhang Ouyang, Xueyan Jiang, Ao Shen, Min-Hua Luo, Qifa Liu, Yue-Peng Zhou, Aiping Qin
Reactivation and infection with cytomegalovirus (CMV) are frequently observed in recipients of solid organ transplants, bone marrow transplants, and individuals with HIV infection. This presents an increasing risk of allograft rejection, opportunistic infection, graft failure, and patient mortality. Among immunocompromised hosts, interstitial pneumonia is the most critical clinical manifestation of CMV infection. Recent studies have demonstrated the potential therapeutic benefits of exosomes derived from mesenchymal stem cells (MSC-exos) in preclinical models of acute lung injury, including pneumonia, ARDS, and sepsis...
April 16, 2024: Viruses
https://read.qxmd.com/read/38675841/human-herpes-virus-6-hhv-6-reactivation-after-hematopoietic-cell-transplant-and-chimeric-antigen-receptor-car-t-cell-therapy-a-shifting-landscape
#53
REVIEW
Eleftheria Kampouri, Guy Handley, Joshua A Hill
HHV-6B reactivation affects approximately half of all allogeneic hematopoietic cell transplant (HCT) recipients. HHV-6B is the most frequent infectious cause of encephalitis following HCT and is associated with pleiotropic manifestations in this setting, including graft-versus-host disease, myelosuppression, pneumonitis, and CMV reactivation, although the causal link is not always clear. When the virus inserts its genome in chromosomes of germ cells, the chromosomally integrated form (ciHHV6) is inherited by offspring...
March 24, 2024: Viruses
https://read.qxmd.com/read/38675820/hepatitis-b-vaccine-four-decades-on
#54
REVIEW
Maria Mironova, Marc G Ghany
Hepatitis B virus is a substantial contributor to cirrhosis and hepatocellular carcinoma (HCC) globally. Vaccination is the most effective method for prevention of hepatitis B and its associated morbidity and mortality, and the only method to prevent infection with hepatitis D virus. The hepatitis B vaccine has been used worldwide for more than four decades; it is available in a single- or triple-antigen form and in combination with vaccines against other infections. Introduction of the vaccine and administration at birth led to sustained decline in mother-to-child transmission, chronic hepatitis B, and HCC, however, global birth dose coverage remains suboptimal...
April 18, 2024: Vaccines
https://read.qxmd.com/read/38675758/live-attenuated-vaccines-in-pediatric-solid-organ-transplant
#55
REVIEW
Christopher Hartley, Tina Thomas, Sara Kathryn Smith, Wikrom Karnsakul
Measles, mumps, rubella (MMR), and varicella incidence rates have increased due to the delayed vaccination schedules of children secondary to the COVID-19 pandemic. Decreased herd immunity creates a risk for immunocompetent children and immunocompromised individuals in the community. Historically, live-attenuated vaccines (MMR and varicella) were recommended before solid organ transplants. The amount of time before transplant when this is appropriate is often debated, as is the utility of vaccine titers. MMR and varicella vaccines previously were not recommended in immunocompromised patients post-solid organ transplant due to the undue risk of transmission and posed infection risk...
April 1, 2024: Vaccines
https://read.qxmd.com/read/38675750/spike-specific-memory-b-cell-response-in-hematopoietic-cell-transplantation-recipients-following-multiple-mrna-1273-vaccinations-a-longitudinal-observational-study
#56
JOURNAL ARTICLE
Elena Pettini, Annalisa Ciabattini, Fabio Fiorino, Jacopo Polvere, Gabiria Pastore, Monica Tozzi, Francesca Montagnani, Giuseppe Marotta, Alessandro Bucalossi, Donata Medaglini
Preventing SARS-CoV-2 infection is of utmost importance in allogeneic hematopoietic cell transplantation patients (allo-HCT), given their heightened susceptibility to adverse outcomes associated with SARS-CoV-2 infection. However, limited data are available regarding the immune response to COVID-19 vaccines in these subjects, particularly concerning the generation and persistence of spike-specific memory response. Here, we analyzed the spike-specific memory B cells in a cohort of allo-HCT recipients vaccinated with multiple doses of the mRNA-1273 vaccine and monitored the spike-specific antibody response from baseline up to one month after the fourth dose...
March 29, 2024: Vaccines
https://read.qxmd.com/read/38675390/significance-of-cytomegalovirus-gb-genotypes-in-adult-patients-undergoing-hematopoietic-stem-cell-transplantation-insights-from-a-single-centre-investigation
#57
JOURNAL ARTICLE
Tamara Vasiljevic, Marko Jankovic, Ana Tomic, Ida Bakrac, Stefan Radenovic, Danijela Miljanovic, Aleksandra Knezevic, Tanja Jovanovic, Irena Djunic, Milena Todorovic-Balint
INTRODUCTION: Cytomegalovirus (CMV) infection is a major clinical issue after allogeneic hematopoietic stem cell transplantation (HSCT). The CMV envelope glycoproteins are key in viral pathogenesis; the glycoprotein B (gB) encoded by the UL55 gene might be an important determinant of viral virulence and disease severity marker in patients treated with allogeneic HSCT. Our aim was to investigate the molecular diversity of CMV gB and inquire into the associations between UL55 gene variations and clinical manifestations in adult patients treated with allogeneic HSCT...
March 27, 2024: Pharmaceuticals
https://read.qxmd.com/read/38674772/acute-hepatitis-of-unknown-origin-in-children-analysis-of-17-cases-admitted-to-the-bambino-ges%C3%A3-children-s-hospital-in-rome
#58
JOURNAL ARTICLE
Velia Chiara Di Maio, Leonarda Gentile, Rossana Scutari, Luna Colagrossi, Luana Coltella, Stefania Ranno, Giulia Linardos, Daniela Liccardo, Maria Sole Basso, Andrea Pietrobattista, Simona Landi, Lorena Forqué, Marta Ciofi Degli Atti, Lara Ricotta, Andrea Onetti Muda, Giuseppe Maggiore, Massimiliano Raponi, Carlo Federico Perno, Cristina Russo
This study described 17 cases of children admitted to the Bambino Gesù Children's Hospital with acute hepatitis of unknown origin between mid-April and November 2022. Following the World Health Organization's working case definition of probable cases, 17 children, with a median age of 2.1 years (interquartile range: 1.0-7.1), presenting with acute hepatitis non-AE, with serum transaminase >500 IU/L, were included in the study. A pre-specified set of microbiological tests was performed on different biological specimens for all pediatric patients...
April 19, 2024: Microorganisms
https://read.qxmd.com/read/38674699/monocentric-retrospective-study-on-infectious-complications-within-one-year-after-solid-organ-transplantation-at-a-belgian-university-hospital
#59
JOURNAL ARTICLE
Céline Van Den Daele, Delphine Martiny, Isabelle Etienne, Delphine Kemlin, Ana Roussoulières, Youri Sokolow, Desislava Germanova, Thierry Gustot, Leda Nobile, Maya Hites
The epidemiology, diagnostic methods and management of infectious complications after solid-organ transplantation (SOT) are evolving. The aim of our study is to describe current infectious complications in the year following SOT and risk factors for their development and outcome. We conducted a retrospective study in adult SOT recipients in a Belgian university hospital between 2018 and 2019. We gathered demographic characteristics, comorbidities leading to transplantation, clinical, microbiological, surgery-specific and therapeutic data concerning infectious episodes, and survival status up to one year post-transplantation...
April 9, 2024: Microorganisms
https://read.qxmd.com/read/38674666/evaluation-of-t-cell-response-to-sars-cov-2-in-kidney-transplant-recipients-receiving-monoclonal-antibody-prophylaxis-and-the-utility-of-a-bivalent-mrna-vaccine-booster-dose
#60
JOURNAL ARTICLE
Dominique Bertrand, Charlotte Laurent, Mathilde Lemoine, Ludivine Lebourg, Mélanie Hanoy, Frank Le Roy, Dorian Nezam, Diana Pruteanu, Steven Grange, Tristan De Nattes, Véronique Lemée, Dominique Guerrot, Sophie Candon
Monoclonal antibodies have been administered to kidney transplant recipients (KTRs) with a poor or non-responder status to SARS-CoV-2 vaccination. The cellular response to SARS-CoV-2 has been poorly studied in this context. We assessed the T cell response to SARS-CoV-2 in 97 patients on the day of the injection of tixagevimab/cilgavimab using an IFNγ enzyme-linked immunospot assay (ELISPOT). Among the 97 patients, 34 (35%) developed COVID-19 before the injection. Twenty-nine (85.3%) had an ELISPOT compatible with a SARS-CoV-2 infection...
April 2, 2024: Microorganisms
keyword
keyword
63303
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.